COLL

COLLEGIUM PHARMACEUTICAL INC

COLL·19459J104·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

COLL (COLLEGIUM PHARMACEUTICAL INC) is held by 141 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($197M), Invesco Ltd. ($68.1M), FULLER & THALER ASSET MANAGEMENT, INC. ($59.1M). Net institutional sentiment: Mixed.

141
Holders
(9 Elite)
$1.1B
Total Value
62% (146)
Consensus
90 buying - 56 selling
13F: Insider & Congress: Updated regularly
COLL

Smart Money Verdict

View all
Loading verdict
Held by 141 funds
9 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders May 18, 2026 · Activists Aug 24, 2026 · Congress none

ActivistMIMillennium Management LLC5.6%Aug 24, 2026
ActivistPGPRINCIPAL GLOBAL INVESTORS5.0%Aug 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
5.4M(+6.0%)$197M0.0%-5.48%
32
Increased
1.9M(+18.3%)$68.1M0.0%-5.27%
35
Increased
1.6M(+8.9%)$59.1M0.2%-33.35%
38
Increased
1.6M(+26.1%)$59.1M0.0%+9.18%
36
Increased
1.5M(+7.3%)$55.3M0.0%-12.63%
32
Increased
1.4M(+2.9%)$50.9M0.0%-15.08%
30
Increased
1.4M(+3.5%)$50M0.0%-17.08%
30
Decreased
1.4M(-7.0%)$49.5M0.1%+11.66%
0
Increased
890,886(+8.7%)$32.3M0.0%+18.55%
31
Increased
837,877(+0.6%)$30.3M0.0%+12.47%
29
Increased
760,252(+21.6%)$27.5M0.0%-7.37%
34
Increased
740,081(+8.8%)$26.8M0.0%-17.44%
31
Increased
736,925(+104.2%)$26.7M0.0%-19.76%
46
Decreased
621,920(-11.6%)$22.5M0.0%-35.65%
0
Decreased
556,927(-3.2%)$20.2M0.0%-17.11%
0
Increased
534,756(+3.8%)$19.4M0.0%-15.65%
29
Increased
491,627(+6.7%)$17.8M0.0%-21.45%
30
Decreased
486,601(-1.7%)$17.6M0.0%+0.43%
0
Decreased
431,447(-30.6%)$15.6M0.0%-17.26%
0
Increased
391,783(+8.3%)$14.2M0.0%+53.80%
30

Showing 1-20 of 151

1 / 8
COLLCOLLCOLLEGIUM PHARMACEUTICAL INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used